Orion Portfolio Solutions, LLC Bluebird Bio, Inc. Transaction History

Orion Portfolio Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $1,756 - $2,231	-51 Closed	0 $0
Q2 2020 Aug 19, 2020	SELL	$27.12 - $45.97 $1,735 - $2,942	-64 Reduced 55.65%	51 $3,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $1,151 - $2,794	44 Added 61.97%	115 $5,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $3,334 - $4,378	71 New	71 $6,000

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $644M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.